Medline (MDLN) Stock Price, News & Analysis

Company Overview

Medline Industries, Inc. is a healthcare company that manufactures and distributes medical supplies, clinical products and equipment to hospitals, health systems, physician practices, long-term care facilities, surgery centers and other healthcare providers. Its offerings are designed to support patient care, surgical procedures, infection prevention and healthcare facility operations.

The company’s product portfolio includes surgical instruments and supplies, exam gloves and protective apparel, wound care products, patient-care items, respiratory and monitoring equipment, laboratory supplies, durable medical equipment and products for environmental and facility management. Medline also provides supply-chain, logistics, inventory-management and data services intended to help healthcare organizations manage procurement and standardize clinical products.

Founded in 1966, Medline has grown from a family business into a large medical-supply manufacturer and distributor serving customers in the United States and international markets. The company operates manufacturing, distribution and healthcare-support activities across a global network. Medline is led by Chief Executive Officer Jim Boyle.

Key Stats

• Today's Range: $34.88 to $35.72
• 50-Day Range: $31.64 to $42.04
• 52-Week Range: $31.49 to $50.88
• Volume: 13.27 million shs
• Average Volume: 8.46 million shs
• Market Capitalization: $46.82 billion
• P/E Ratio: 45.08
• Dividend Yield: N/A
• Price Target: $46.88
• Consensus Rating: Moderate Buy

Medline Stock Analysis - MarketRank™

Medline scored higher than 51% of companies evaluated by MarketBeat, and ranked 354th out of 887 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Medline has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 2 strong buy ratings, 21 buy ratings, 5 hold ratings, and 1 sell rating.

Upside Potential

Medline has a consensus price target of $46.88, representing about 31.7% upside from its current price of $35.61.

Amount of Analyst Coverage

Medline has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: -1.99%

Earnings Growth

Earnings for Medline are expected to decrease by -1.99% in the coming year, from $1.51 to $1.48 per share.

Price to Earnings Growth Ratio

Medline has a PEG Ratio of 3.06. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Medline has a P/B Ratio of 2.43. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

3.17% of the float of Medline has been sold short.

Short Interest Ratio / Days to Cover

Medline has a short interest ratio ("days to cover") of 6.43.

Change versus previous month

Short interest in Medline has recently increased by 4.63%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Medline does not currently pay a dividend.

Dividend Growth

Medline does not have a long track record of dividend growth.

News and Social Media

• Score: 1.9 / 5
• News Sentiment: 0.04

News Sentiment

Medline has a news sentiment score of 0.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 13 news articles for Medline this week, compared to 7 articles on an average week.

Search Interest

Only 10 people have searched for MDLN on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

MarketBeat Follows

Only 4 people have added Medline to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Medline insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $158,259,454.00 in company stock.

Percentage Held by Insiders

0.81% of the stock of Medline is held by insiders.

Percentage Held by Institutions

Medline has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/05/2026
• Today: 10/03/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Supplies
• Current Symbol: NASDAQ:MDLN
• CIK: 2046386
• Web: www.medline.com
• Phone: (847) 949-3000
• Fax: N/A
• Employees: 45,000
• Year Founded: 1966

Price Target and Rating

• Average Price Target for Medline: $46.88
• High Price Target: $56.00
• Low Price Target: $34.00
• Potential Upside/Downside: +31.7%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.83
• Research Coverage: 29 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 45.08
• Forward P/E Ratio: 23.58
• P/E Growth: 3.06
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.66
• Current Ratio: 4.33
• Quick Ratio: 2.61

Sales & Book Value

• Annual Sales: $28.43 billion
• Price / Sales: 1.65
• Cash Flow: $1.70 per share
• Price / Cash Flow: 20.99
• Book Value: $14.68 per share
• Price / Book: 2.43

Miscellaneous

• Outstanding Shares: 1,314,710,000
• Free Float: 1,304,058,000
• Market Cap: $46.82 billion
• Optionable: N/A
• Beta: N/A